Ian Battersby offers his thoughts on the EIS market in the run-up to the tax year-end, the potential impact of changes announced in the Budget and the proposals outlined in the much-anticipated Patient Capital Review
The waiting is over and, while the finer detail is still to emerge in some respects, we now know pretty much where we all stand. Realistically, I doubt there can be too many complaints about how ‘financing...
Suspension remains 'in best interests of all investors'
Our weekly heads-up for advisers
'UK investment case remains strong'
'No viable alternative'